NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

Rwanda’s tourism industry raked in $647 million (approx. Rwf923billion) revenue in 2024, representing a slight increase of 4.3 percent compared to 2023, according to an annual Rwanda Development Board ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...